Tue, November 2, 2021
Mon, November 1, 2021
Sun, October 31, 2021
Sat, October 30, 2021
Fri, October 29, 2021
Thu, October 28, 2021
Wed, October 27, 2021

David Lebovitz Maintained (BPMC) at Hold with Increased Target to $111 on, Oct 29th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-111-on-oct-29th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Lebovitz of Morgan Stanley, Maintained "Blueprint Medicines Corporation" (BPMC) at Hold with Increased Target from $96 to $111 on, Oct 29th, 2021.

David has made no other calls on BPMC in the last 4 months.



There is 1 other peer that has a rating on BPMC. Out of the 1 peers that are also analyzing BPMC, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Increased Target to $122 on, Thursday, October 28th, 2021

Publication Contributing Sources